Management of Atopic Dermatitis with Individualised Homoeopathic Treatment

Abstract

Skin being an important protective organ of body has its own functional and cosmetic values. Atopic dermatitis (AD) is a disease comprising of heterogenous skin manifestations with intense itching. AD affects people of all age groups and ethnicities and has psychosocial impact on the patient. Being the leading cause of global burden of skin disease, this disease also enhances the chances of developing food allergy, allergic asthma etc. Moreover, due to poor hygiene and decreased protective barrier function, AD often gets infected by certain pathogens (Staphylococcus aureus, Malassezia, Molluscum etc.), as a result of which patient suffers from life-threatening complications. Absence of specific diagnostic test with gradual escalation in the disease burden makes it one of the chief concerns for the health care workers. For dermatological diseases, homoeopathy stands out as a prime choice for many patients. In this case, a 72-year-old male patient presented with symptoms of dry, itchy eruptions on right hand for the last 2 years. He also developed similar itching eruptions in and around navel. The patient was clinically diagnosed with AD and treated with individualised homoeopathic treatment. Initially, he was prescribed Tuberculinum which improved the patient and finally he was cured by Sulphur.

Keywords

atopic dermatitis - case report - homoeopathy

Publication History

Article published online:
19 April 2022

• Reference

• 1 Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI. ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009; 124 (06) 1251-8.e23
• 2 Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol 2013; 132 (05) 1132-1138
• 3 Hay RJ, Johns NE, Williams HC. et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014; 134 (06) 1527-1534
• 4 Williams HC. Ed. Atopic Dermatitis: The Epidemiology, Causes and Prevention of Atopic Eczema. Cambridge: Cambridge University Press; 2000
• 5 Abuabara K, Hoffstad O, Troxel AB, Gelfand JM, McCulloch CE, Margolis DJ. Patterns and predictors of atopic dermatitis disease control past childhood: an observational cohort study. J Allergy Clin Immunol 2018; 141 (02) 778-780.e6
• 6 Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM. The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies. Allergy 2018; 73 (03) 696-704
• 7 Neena K. Illustrated Synopsis of Dermatology and Sexually Transmitted Diseases-. Elsevier; 2010. 4E. 85-88
• 8 Stefanovic N, Flohr C, Irvine AD. The exposome in atopic dermatitis. Allergy 2020; 75 (01) 63-74
• 9 James WD, Burger TG, Elston DM. Andrews' Diseases of the Skin. ; 16E; 62-70
• 10 Malik K, Heitmiller KD, Czarnowicki T. An update on the pathophysiology of atopic dermatitis. Dermatol Clin 2017; 35 (03) 317-326
• 11 Rutter CE, Silverwood RJ, Williams HC. et al; ISAAC Phase Three Study Group. Are environmental factors for atopic eczema in ISAAC phase three due to reverse causation?. J Invest Dermatol 2019; 139 (05) 1023-1036
• 12 Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974; 90 (05) 525-530
• 13 Totté JE, van der Feltz WT, Hennekam M, van Belkum A, van Zuuren EJ, Pasmans SG. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol 2016; 175 (04) 687-695
• 14 Glatz M, Buchner M, von Bartenwerffer W. et al. Malassezia spp.-specific immunoglobulin E level is a marker for severity of atopic dermatitis in adults. Acta Derm Venereol 2015; 95 (02) 191-196
• 15 Coutinho SD, Paula CR. Proteinase, phospholipase, hyaluronidase and chondroitin-sulphatase production by Malassezia pachydermatis. Med Mycol 2000; 38 (01) 73-76
• 16 Beck LA, Boguniewicz M, Hata T. et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol 2009; 124 (02) 260-269 , 269.e1–269.e7
• 17 Ernst E. The usage of complementary therapies by dermatological patients: a systematic review. Br J Dermatol 2000; 142 (05) 857-861
• 18 Johnston GA, Bilbao RM, Graham-Brown RA. The use of complementary medicine in children with atopic dermatitis in secondary care in Leicester. Br J Dermatol 2003; 149 (03) 566-571
• 19 Baron SE, Goodwin RG, Nicolau N, Blackford S, Goulden V. Use of complementary medicine among outpatients with dermatologic conditions within Yorkshire and South Wales, United Kingdom. J Am Acad Dermatol 2005; 52 (04) 589-594
• 20 Witt CM, Lüdtke R, Willich SN. Homeopathic treatment of patients with psoriasis–a prospective observational study with 2 years follow-up. J Eur Acad Dermatol Venereol 2009; 23 (05) 538-543
• 21 Shah SF, Mubeen SM, Mansoor S. Concepts of homeopathy among general population in Karachi, Pakistan. J Pak Med Assoc 2010; 60 (08) 667-670
• 22 Jensen P. Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol 1990; 70 (05) 421-424
• 23 Simonart T, Kabagabo C, De Maertelaer V. Homoeopathic remedies in dermatology: a systematic review of controlled clinical trials. Br J Dermatol 2011; 165 (04) 897-905
• 24 Grewe M, Bruijnzeel-Koomen CA, Schöpf E. et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19 (08) 359-361
• 25 Bellavite P, Conforti A, Pontarollo F, Ortolani R. Immunology and homeopathy. 2. Cells of the immune system and inflammation. Evid Based Complement Alternat Med 2006; 3 (01) 13-24